logo
Kennedy says US is pulling funding from global vaccine group Gavi

Kennedy says US is pulling funding from global vaccine group Gavi

LONDON (AP) — U.S. Health Secretary Robert F. Kennedy Jr. says the country is pulling its support from the vaccines alliance Gavi, saying the organization has 'ignored the science' and 'lost the public trust.'
A video of Kennedy's short speech was shown to a Gavi meeting in Brussels on Wednesday, where the organization that has paid for more than 1 billion children to be vaccinated through routine immunization programs was hoping to raise at least $9 billion for the next five years.
Kennedy, a longtime vaccine skeptic, mentioned Gavi's partnership with the World Health Organization during COVID-19, accusing them of silencing 'dissenting views' and 'legitimate questions' about vaccine safety. His speech also cast doubt on the diphtheria, tetanus and pertussis vaccine — which WHO and other health agencies have long deemed to be safe and effective.
Gavi said in a statement Thursday that its 'utmost concern is the health and safety of children,' adding that any decision it makes on vaccines to buy is done in accordance with recommendations issued by WHO's expert vaccine group.
Some doctors in the United States criticized the decision. Dr. Paul Offit, director of the Vaccine Center at the Children's Hospital of Philadelphia, said it was 'incredibly dangerous' and warned that defunding immunization would put millions of children at risk.
Gavi is a public-private partnership including WHO, UNICEF, the Gates Foundation and the World Bank, and it is estimated that the vaccination programs have saved 18 million lives. The United States has long been one of its biggest supporters; before President Donald Trump's re-election, the country had pledged $1 billion through 2030.
In just under four minutes, Kennedy called on Gavi 'to justify the $8 billion America has provided in funding since 2001,' saying officials must 'consider the best science available, even when that science contradicts established paradigms.' Kennedy said until that happens, the U.S. won't contribute further to Gavi.
The health secretary zeroed in on the COVID-19 vaccine, which WHO, Gavi and other health authorities have recommended for pregnant women, saying they are at higher risk of severe disease. Kennedy called that a 'questionable' recommendation; his U.S. Centers for Disease Control and Prevention recently stopped recommending it.
He also criticized Gavi for funding of a rollout a vaccine to prevent diphtheria, tetanus and pertussis in poorer countries, saying he'd seen research that concluded that young girls who got the vaccine were more likely to die from all other causes than children who weren't immunized.
Gavi said scientists had reviewed all available data, including any studies that raised concerns, and that the diphtheria, tetanus and pertussis vaccine has 'played a key role in helping halve childhood mortality.'
Some observational studies have shown that vaccinated girls do have a higher death rate compared to unvaccinated children, but there is no evidence the deaths are caused by the vaccine. But Offit said the studies cited by Kennedy were not convincing and that research examining links between vaccinations and deaths did not prove a causal connection.
'There's no mechanism here which makes biological sense for why the (diphtheria, tetanus and pertussis vaccine) might result in more children dying,' Offit said.
Doctors Without Borders on Thursday predicted 'countless children will die from vaccine-preventable diseases' as a result of the U.S. withdrawing support for Gavi.
'To invoke misleading and inaccurate claims about vaccine safety as the pretext for cutting all global vaccine funding is cruel and reckless,' said Mihir Mankad, the charity's global health advocacy and policy director in the U.S. 'When we vaccinate in the community, parents line up for hours to give their children a chance to be protected from these deadly diseases.
'For these children, vaccination programs ... are a matter of life and death.'
___

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Body fat predicts major health risk that BMI misses, researchers say
Body fat predicts major health risk that BMI misses, researchers say

Fox News

time36 minutes ago

  • Fox News

Body fat predicts major health risk that BMI misses, researchers say

Body mass index (BMI) may not be the most accurate predictor of death risk. A new study from the University of Florida found that BMI — a measurement that is commonly used to determine whether a person's weight is in a healthy range for their height — is "deeply flawed" in terms of predicting mortality. Instead, one's level of body fat is "far more accurate," concluded the study, which was published this week in the Annals of Family Medicine. To measure participants' body fat, the researchers used a method called bioelectrical impedance analysis (BIA), which uses a device to measure the resistance of body tissue to a small electrical current. Over a 15-year period, those who had high body fat were found to be 78% more likely to die than those who had healthy body fat levels, researchers found. They were also more than three times as likely to die of heart disease, the study noted. BMI — which is calculated by dividing weight by height, squared — was described as "entirely unreliable" in predicting the risk of death over a 15-year period from any cause. The study included 4,252 people in the U.S. and pulled data from the National Health and Nutrition Examination Survey. BMI should not be relied upon as a "vital sign" of health, according to senior author Frank Orlando, M.D., medical director of UF Health Family Medicine in Springhill. "I'm a family physician, and on a regular basis, we're faced with patients who have diabetes, heart disease, obesity and other conditions that are related to obesity," Orlando said in a press release for the study. "One of the routine measures we take alongside traditional vital signs is BMI. We use BMI to screen for a person having an issue with their body composition, but it's not as accurate for everyone as vital signs are," he added. BMI has been the international standard for measuring obesity since the 1980s, according to many sources, though some experts have questioned its validity. "I think the study shows it's time to go to an alternative that is now proven to be far better at the job." An individual is considered obese if their BMI is 30 or above, overweight if it is between 25 and 29.9, of "normal" weight in the range of 18.5 to 24.9, or underweight if lower than 18.5. While BMI is easy to calculate, one of its main limitations is that it cannot distinguish between muscle and fat mass, the researchers noted. "For example, people who are bodybuilders can really elevate their body mass index," Orlando said. "But they're healthy even with a BMI indicating that they're obese." "BMI is just so ingrained in how we think about body fat," Mainous added. "I think the study shows it's time to go to an alternative that is now proven to be far better at the job." Other methods, such as a DEXA (dual-energy X-ray absorptiometry) scan, may be even more accurate than BIA, but are much more expensive and not as accessible, the researchers noted. "If you talk to obesity researchers, they're going to say you have to use the DEXA scan because it's the most accurate," Mainous said in the release. "And that's probably true. But it's never going to be viable in a doctor's office or family practice." Dr. Stephen Vogel — a family medicine physician with PlushCare, a virtual health platform with primary care, therapy and weight management options — echoed the limitations of BMI. "It has been an easy measurement tool that helps us understand at-risk groups across various populations and demographics, but it doesn't provide accurate data from patient to patient," the North Carolina-based doctor, who was not involved in the study, told Fox News Digital. "These findings don't challenge the assumptions about BMI — they strengthen the message that new standards, delivered in a consistent and low-cost way, would provide better nuance for the individual when it comes to their overall physical health." "The main strengths of this study are a better correlation to an individual's risk of morbidity and mortality — however, the limitations lie in the fact that we don't have enough data to determine the right cutoff for these numbers, or to identify the right tools that will be both accurate and precise across the population," Vogel said. The researchers also acknowledged that body fat percentage thresholds haven't yet been as standardized as BMI and waist circumference. Also, the age range of the participants in the study was limited by the data source. "Future studies should extend this comparison of body fat to BMI in older adults," the researchers wrote. The study was also limited by focusing only on mortality as an outcome, they noted, without taking into account any developing diseases — such as heart failure or cancer — that could deepen the understanding of body fat as a risk factor. The goal, according to Vogel, is to have a cost-effective, consistent method that can be used across the population with reliable accuracy. "These data will drive better discussions in the doctor's office, as well as public health initiatives with the goal of improving the health of all." "Benefits would come in the form of a more detailed list of information that helps providers and patients make informed decisions about the patient's health, which is ideal," Vogel noted. "I'm hopeful there's enough buzz around these measures that steps will continue to be taken toward regular implementation." For more Health articles, visit The researchers are hopeful that once standards are validated, measuring body fat percentage with bioelectrical impedance analysis could become standard of care. They added, "These data will drive better discussions in the doctor's office, as well as public health initiatives with the goal of improving the health of all."

Citi Expresses Optimism for Eli Lilly and Company (LLY)
Citi Expresses Optimism for Eli Lilly and Company (LLY)

Yahoo

time40 minutes ago

  • Yahoo

Citi Expresses Optimism for Eli Lilly and Company (LLY)

Eli Lilly and Company (NYSE:LLY) is one of the 13 Best Long Term Growth Stocks to Invest in Right Now. On June 25, Citi reported that 'compelling' data shows that Eli Lilly and Company (NYSE:LLY) and Novo Nordisk (NVO) have turned obesity into a treatable disease from a lifestyle-based condition. The firm models more than $40 billion in obesity sales by 2030, well above the consensus estimates of $25 billion. Citi stated that as the obesity space evolves from injectables to convenient orals, such as orforglipron, the emergence of a 'dynamic' consumer-centric market is possible, and LillyDirect by Eli Lilly and Company (NYSE:LLY) is well-positioned to connect high consumer visibility for orforglipron with global access. In a research note, Citi further stated that it estimated penetration rates via income-based tiers for pricing and out-of-pocket costs in low- and mid-body mass index patients. The results place Eli Lilly and Company's (NYSE:LLY) consumer platform opportunity at $15B, which is not assumed in the firm's model. It thus believes that Eli Lilly and Company's (NYSE:LLY) is in a position to expedite access outside the US, employing a centralized out-of-pocket payment model instead of the traditional country-by-country launch. It contended that an 'income-based tiered pricing of orforglipron via LillyDirect could unlock unprecedented volume, all the while allowing it to maintain overall pricing power.' Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span oncology, diabetes, immunology, neuroscience, and other therapies. Investors are bullish on Eli Lilly and Company (NYSE:LLY) due to its in-demand GLP-1 drugs, used to treat diabetes and obesity, which are still in their early growth stages, and the company's strong financials. While we acknowledge the potential of LKQ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio

Why a G.O.P. Medicaid Requirement Could Set States Up for Failure
Why a G.O.P. Medicaid Requirement Could Set States Up for Failure

New York Times

time41 minutes ago

  • New York Times

Why a G.O.P. Medicaid Requirement Could Set States Up for Failure

The strict Medicaid work requirement at the center of the Republicans' major policy bill wouldn't just require millions of poor Americans to prove they are employed to sign up for health insurance. It would also require dozens of states to quickly build expensive and complex software systems to measure and track who is eligible. This new responsibility for states, whose existing Medicaid computer systems are often outdated, would be accompanied by reduced federal funding through other changes in the bill. The result, according to state officials, software developers and policy experts, could be major failures in state systems for enrolling people in Medicaid. 'That's how happens,' said Julie Brinn Siegel, a former top Biden administration budget official, referring to the Obama administration's botched launch of the online Affordable Care Act enrollment portal in 2013. Ms. Siegel and others familiar with Medicaid systems envision problems like websites that don't load or incorrectly tell applicants they are not eligible. And Medicaid workers may be overwhelmed as they try to run call centers and process applications. The fallout could mean eligible Americans will have their coverage dropped. Republicans contend that the work requirement achieves twin goals: It ensures that the government directs resources to Americans who are contributing to society, while saving money to help finance an extension of President Trump's tax cuts. Want all of The Times? Subscribe.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store